| SC 13G | 2024-03-18 | CITADEL ADVISORS LLC | Atara Biotherapeutics, Inc. | - | 6.4% | EDGAR |
| SC 13G/A | 2024-02-14 | Redmile Group, LLC | Atara Biotherapeutics, Inc. | 10,301,409 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-14 | MAVERICK CAPITAL LTD | Atara Biotherapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Atara Biotherapeutics, Inc. | 6,686,043 | 6.6% | EDGAR |
| SC 13G/A | 2024-02-09 | WASATCH ADVISORS LP | Atara Biotherapeutics, Inc. | - | - | EDGAR |
| SC 13G/A | 2024-02-06 | GOLDMAN SACHS GROUP INC | Atara Biotherapeutics, Inc. | 580,629 | 0.6% | EDGAR |
| SC 13G/A | 2024-01-26 | BlackRock Inc. | Atara Biotherapeutics, Inc. | 7,087,213 | 7.0% | EDGAR |
| SC 13G/A | 2024-01-22 | STATE STREET CORP | Atara Biotherapeutics, Inc. | - | 2.7% | EDGAR |
| SC 13G/A | 2024-01-09 | BAUPOST GROUP LLC/MA | Atara Biotherapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-12-07 | JPMORGAN CHASE & CO | Atara Biotherapeutics, Inc. | 2,206,929 | 2.1% | EDGAR |
| SC 13G | 2023-11-21 | EcoR1 Capital, LLC | Atara Biotherapeutics, Inc. | 10,067,043 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | Atara Biotherapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Redmile Group, LLC | Atara Biotherapeutics, Inc. | 9,837,493 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-14 | MAVERICK CAPITAL LTD | Atara Biotherapeutics, Inc. | 6,291,013 | 6.6% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Atara Biotherapeutics, Inc. | 132,521 | 0.1% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Atara Biotherapeutics, Inc. | 7,211,048 | 7.6% | EDGAR |
| SC 13G | 2023-02-08 | WASATCH ADVISORS INC | Atara Biotherapeutics, Inc. | - | - | EDGAR |
| SC 13G | 2023-02-07 | GOLDMAN SACHS GROUP INC | Atara Biotherapeutics, Inc. | 6,108,260 | 6.4% | EDGAR |
| SC 13G | 2023-02-03 | STATE STREET CORP | Atara Biotherapeutics, Inc. | - | 8.1% | EDGAR |
| SC 13G/A | 2023-01-24 | BlackRock Inc. | Atara Biotherapeutics, Inc. | 9,152,149 | 9.6% | EDGAR |